HomeCompareLHDX vs PM

LHDX vs PM: Dividend Comparison 2026

LHDX yields 442.18% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LHDX wins by $24061.26M in total portfolio value
10 years
LHDX
LHDX
● Live price
442.18%
Share price
$0.45
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24061.31M
Annual income
$16,652,908,317.91
Full LHDX calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — LHDX vs PM

📍 LHDX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLHDXPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LHDX + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LHDX pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LHDX
Annual income on $10K today (after 15% tax)
$37,585.67/yr
After 10yr DRIP, annual income (after tax)
$14,154,972,070.22/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, LHDX beats the other by $14,154,969,952.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LHDX + PM for your $10,000?

LHDX: 50%PM: 50%
100% PM50/50100% LHDX
Portfolio after 10yr
$12030.68M
Annual income
$8,326,455,404.96/yr
Blended yield
69.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

LHDX
Analyst Ratings
1
Hold
1
Sell
Consensus: Hold
Altman Z
-3.0
Piotroski
2/9
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LHDX buys
0
PM buys
0
No recent congressional trades found for LHDX or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLHDXPM
Forward yield442.18%3.48%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$24061.31M$49.6K
Annual income after 10y$16,652,908,317.91$2,492.02
Total dividends collected$23397.53M$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldBuy

Year-by-year: LHDX vs PM ($10,000, DRIP)

YearLHDX PortfolioLHDX Income/yrPM PortfolioPM Income/yrGap
1← crossover$54,918$44,218.44$11,648$408.29+$43.3KLHDX
2$285,717$226,953.99$13,589$495.90+$272.1KLHDX
3$1,409,215$1,103,497.88$15,877$603.21+$1.39MLHDX
4$6,594,479$5,086,619.59$18,580$734.88+$6.58MLHDX
5$29,301,933$22,245,840.16$21,781$896.75+$29.28MLHDX
6$123,733,671$92,380,602.86$25,578$1,096.12+$123.71MLHDX
7$496,971,503$364,576,474.39$30,092$1,342.17+$496.94MLHDX
8$1,900,271,005$1,368,511,496.83$35,470$1,646.46+$1900.24MLHDX
9$6,923,738,907$4,890,448,931.51$41,892$2,023.58+$6923.70MLHDX
10$24,061,308,948$16,652,908,317.91$49,578$2,492.02+$24061.26MLHDX

LHDX vs PM: Complete Analysis 2026

LHDXStock

Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California.

Full LHDX Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this LHDX vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LHDX vs SCHDLHDX vs JEPILHDX vs OLHDX vs KOLHDX vs MAINLHDX vs MOLHDX vs BTILHDX vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.